AccessibilityHelpAbout Us
Zentek logo

Zentek(TSXV) ZEN

Market CapCA$93.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+21%
5 Year-88%
1 Year-38%
1 Month-8%
CA$0.71
-4.05%
-0.03Today
Zentek last closing stock price
MetricPriceDate
Last closeCAD 0.712026-09-28
Zentek stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.58%CAD 0.762026-09-21
1 month-7.79%CAD 0.772026-08-28
3 month+9.23%CAD 0.652026-06-30
Year to date-20.22%CAD 0.892025-12-31
1 year-37.72%CAD 1.142025-09-26
3 year-59.2%CAD 1.742023-09-29
5 year-87.63%CAD 5.742021-09-29
Since inception+21.31%CAD 0.612010-12-23

Zentek Financials at a Glance

Market Cap

CA$93.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$108.25K

Net Income (TTM)

-CA$10.45M

EPS (TTM)

-CA$0.10

P/E Ratio

-7.66

Dividend

CA$0.00

Beta (Volatility)

0.10 (Low)

Price

CA$0.71

Volume

15,274

Open

CA$0.74

Previous Close

CA$0.71

Daily Range

CA$0.71 - CA$0.74

52-Week Range

CA$0.52 - CA$1.50

Estimated Earnings Date

Nov 12, 2026

ZEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zentek

Zentek Ltd. is a Canadian company focused on the exploration and advancement of graphene and related nanomaterials. The firm fully owns the Albany Graphite project in Northern Ontario and develops innovative products leveraging graphene technology.

Products and Services
  • Graphene-based antimicrobial coatings for various applications
  • Point-of-care diagnostics utilizing graphene compounds
  • Synthesis of graphene, graphene oxide, and quantum dots
Growth Outlook
  • Expansion into healthcare with innovative graphene-based products
  • Increasing demand for antimicrobial solutions in various industries
  • Strategic partnerships to enhance product development and market reach
Financial Highlights
  • Recent quarterly revenue of CAD 36,767, showing potential for growth
  • Cash and cash equivalents increased to CAD 16,596,696 in Q1 2026
  • Current ratio of 4.65 indicates strong liquidity position
Zentek Ltd. is positioned in the rapidly evolving field of nanotechnology, particularly graphene applications. The company's focus on antimicrobial coatings and point-of-care diagnostics aligns with growing market needs, especially in healthcare. Recent financial data indicates a solid liquidity position, which may support future growth initiatives. The increase in cash reserves suggests a capacity for investment in research and development, essential for maintaining competitive advantage. Overall, Zentek Ltd. presents an intriguing opportunity for investors interested in innovative materials and technologies.
AI Generated • Sep 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10

CEO

Mohammed Jiwan

Website

www.zentek.com

Headquarters

Guelph, ON N1E 6Z1, CA

ZEN Financials

Key Financial Metrics (TTM)

Gross Margin

-5018.33%

Operating Margin

-10055.02%

Net Income Margin

-9652.83%

Return on Equity

-70.73%

Return on Capital

-92.44%

Return on Assets

-33.86%

Earnings Yield

-13.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$93.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

126.62M

Volume

15.27K

Avg. Volume

147.18K

Financials (TTM)

Gross Profit

-CA$5.43M

Operating Income

-CA$10.88M

EBITDA

-CA$10.59M

Operating Cash Flow

-CA$5.07M

Capital Expenditure

-CA$499.65K

Free Cash Flow

-CA$5.57M

Cash & ST Invst.

CA$16.60M

Total Debt

CA$1.93M

Zentek Performance Analysis

Zentek annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 72,855-78.6%
20242024-03-31CAD 29,816-59.1%
20252025-03-31CAD 872,4952826.3%
20262026-03-31CAD 166,048-81.0%
Zentek sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-89.3%
Q32025-12-31952.2%
Q42026-03-31-43.7%
Q12026-06-30-100.0%
Zentek annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.15-57.9%
20242024-03-31CAD -0.12-19.7%
20252025-03-31CAD -0.10-16.2%
20262026-03-31CAD -0.09-5.4%
Zentek sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-53.8%
Q32025-12-31-16.5%
Q42026-03-31-40.3%
Q12026-06-3045.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$0.00

-100.0%

Gross Profit

-CA$1.22M

-4594.5%

Gross Margin

0.00%

N/A

Market Cap

CA$93.70MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$9.37M

N/A

Employees

10

N/A

Net Income

-CA$2.04M

-50.0%

EBITDA

-CA$2.06M

-76.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$16.60M

+474.5%

Total Debt

CA$1.93M

+2.7%

Accounts Receivable

CA$391.78K

-0.7%

Inventory

CA$393.49K

-55.9%

Long Term Debt

CA$1.81M

+6.6%

Short Term Debt

CA$115.17K

-35.2%

Return on Assets

-33.86%

N/A

Return on Invested Capital

-40.20%

N/A

Free Cash Flow

-CA$1.18M

+3.9%

Operating Cash Flow

-CA$1.18M

-0.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDNA.TOMedicenna Therapeutics Corp.
CA$0.40-2.47%
RX.VBioSyent Inc.
CA$16.78+3.58%
CRDL.TOCardiol Therapeutics Inc.
CA$2.39-1.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.23-10.01%
NVDANvidia
$228.86+1.68%
INTCIntel
$116.03-5.67%
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$77.54-0.41%

Questions About ZEN

What is the current price of Zentek?

Zentek is trading at CA$0.71 per share.

What is the 52-week range for Zentek?

Over the past 52 weeks, Zentek has traded between CA$0.52 and CA$1.50.

How much debt does Zentek have?

As of the most recent reporting period, Zentek reported total debt of CA$1.93M.

How much cash does Zentek have on hand?

Zentek reported CA$16.60M in cash and cash equivalents in its most recent financial results.

What is Zentek’s dividend yield?

Zentek does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services